Valiltramiprosate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameValiltramiprosate
Drug Alias NameTramiprosate prodrug (Alzheon)BLU-8499NRM-8499ALZ-801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptorBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlzheon Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlzheon Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A